Cited by 2,833Heart Failure Treatment and ManagementHeart rate and cardiovascular healthCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

Open access

Cohn, Jay N., Johnson, Gary, Ziesche, Susan, Cobb, Frederick, Francis, Gary, Tristani, Felix, Smith, Raphael, Dunkman, W. Bruce, Loeb, Henry, Wong, Maylene, Bhat, Geetha, Goldman, Steven, Fletcher, Ross D., Doherty, James, Hughes, C. Vincent, Carson, Peter, Cintron, Guillermo, Shabetai, Ralph, Haakenson, Clair·1991·New England Journal of Medicine

DOI 10.1056/nejm199108013250502

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: To define better the efficacy of vasodilator therapy in the treatment of chronic congestive heart failure, we compared the effects of hydralazine and isosorbide dinitrate with those of enalapril in 804 men receiving digoxin and diuretic therapy for heart failure. The patients were randomly assigned in a double-blind manner to receive 20 mg of enalapril daily or 300 mg of hydralazine plus 160 mg of isosorbide dinitrate daily. The latter regimen was identical to that used with a similar patient population in the effective-treatment arm of our previous Vasodilator-Heart Failure Trial. RESULTS: Mortality after two years was significantly lower in the enalapril arm (18 percent) than in the hydralazine-isosorbide dinitrate arm (25 percent) (P = 0.016; reduction in mortality, 28.0 percent), and overall mortality tended to be lower (P = 0.08). The lower mortality in the enalapril arm was attributable to a reduction in the incidence of sudden death, and this beneficial effect was more prominent in patients with less severe symptoms (New York Heart Association class I or II). In contrast, body oxygen consumption at peak exercise was increased only by hydralazine-isosorbide dinitrate treatment (P less than 0.05), and left ventricular ejection fraction, which increased with both regimens during the 2 years after randomization, increased more (P less than 0.05) during the first 13 weeks in the hydralazine-isosorbide dinitrate group. CONCLUSIONS: The similar two-year mortality in the hydralazine-isosorbide dinitrate arms in our previous Vasodilator-Heart Failure Trial (26 percent) and in the present trial (25 percent), as compared with that in the placebo arm in the previous trial, (34 percent) and the further survival benefit with enalapril in the present trial (18 percent) strengthen the conclusion that vasodilator therapy should be included in the standard treatment for heart failure. The different effects of the two regimens (enalapril and hydralazine-isosorbide dinitrate) on mortality and physiologic end points suggest that the profile of effects might be enhanced if the regimens were used in combination.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108013250502

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,109
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Self-citation
A placebo-controlled trial of captopril in refractory chronic congestive heart failure
Captopril Multicenter Research Group (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80316-7 · Cited by 588
Vasodilator Therapy of Cardiac Failure
Cohn, J. N., & Franciosa, J. A. (1977) · New England Journal of Medicine · doi:10.1056/nejm197707072970105 · Cited by 483
Self-citation
The role of vasodilator therapy in heart failure
Chatterjee, K., & Parmley, W. W. (1977) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(77)90006-8 · Cited by 315
Vasodilator Therapy for Heart Failure
Cohn, J. N. (1973) · Circulation · doi:10.1161/01.cir.48.1.5 · Cited by 293
Self-citation
Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.
Leier, C. V., Huss, P., Magorien, R. D., & Unverferth, D. V. (1983) · Circulation · doi:10.1161/01.cir.67.4.817 · Cited by 289

Show all 19 references

Research works printed but not linked: 1

Cohn, 1987, Circulation, 76, IV–443

Sorted by citations

Items 601–700 of 1,000

Corcoran Lecture. Angiotensin-converting enzyme inhibition and the heart.
Gavras, H. P. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.813 · Cited by 55
Implications of geographical variation on clinical outcomes of cardiovascular trials
Mentz, R. J., Kaski, J. C., Dan, G., Goldstein, S., Stockbridge, N., Alonso-García, Á., Ruilope, L. M., Martínez, F. A., Zannad, F. M., Pitt, B., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.06.006 · Cited by 54
Antiarrhythmic and Nonantiarrhythmic Drugs for Sudden Cardiac Death Prevention
Das, M. K., & Zipes, D. P. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181d64dde · Cited by 54
Extracellular Vesicles as Protagonists of Diabetic Cardiovascular Pathology
Gustafson, D., Veitch, S., & Fish, J. E. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00071 · Cited by 54
Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience
Kizer, J. R., Cannon, C. P., McCabe, C. H., Mueller, H. S., Schweiger, M. J., Davis, V. G., Perritt, R. L., & Antman, E. M. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70462-x · Cited by 54
Chronic heart failure in the very elderly: Clinical status, survival, and prognostic factors in 188 patients more than 70 years old
Cicoira, M., Davos, C. H., Florea, V. G., Shamim, W., Doehner, W., Coats, A. J. S., & Anker, S. D. (2001) · American Heart Journal · doi:10.1067/mhj.2001.115796 · Cited by 54
Prevalence of self-reported heart failure among US adults: results from the 1999 National Health Interview Survey
Ni, H. (2003) · American Heart Journal · doi:10.1016/s0002-8703(02)94800-3 · Cited by 54
III Diretriz sobre tratamento do infarto agudo do miocárdio
Piegas, L. S., Timerman, A., Nicolau, J. C., Mattos, L. A., Neto, J. M. R., Feitosa, G. S., Avezum, Á., Carvalho, A. C. C., Mansur, A. D. P., Timerman, A., et al. (2004) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2004002200001 · Cited by 58
Cardiovascular Disease in the Elderly
Jackson, C. F., & WENGER, N. K. (2011) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2011.05.003 · Cited by 55
Vascular Reactivity in Heart Failure
Karim, S. M., Rhee, A. Y., Given, A. M., Faulx, M. D., Hoit, B. D., & Brozovich, F. V. (2004) · Circulation Research · doi:10.1161/01.res.0000142736.39359.58 · Cited by 53
Role of Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Aldosterone Antagonists in the Prevention of Atrial and Ventricular Arrhythmias
Makkar, K. M., Sanoski, C. A., & Spinler, S. A. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.1.31 · Cited by 53
Optimizing Drug Therapy in Patients with Cardiovascular Disease: The Impact of Pharmacist‐Managed Pharmacotherapy Clinics in a Primary Care Setting
Geber, J. M., Parra, D., Beckey, N. P., & Korman, L. B. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.9.738.34061 · Cited by 54
Long-Term Prognosis of Dilated Cardiomyopathy Revisited An Improvement in Survival Over the Past 20 Years
Matsumura, Y., Takata, J., Kitaoka, H., Kubo, T., Baba, Y., Hoshikawa, E., Hamada, T., Okawa, M., Hitomi, N., Sato, K., et al. (2006) · Circulation Journal · doi:10.1253/circj.70.376 · Cited by 54
The Relationship Between Cardiothoracic Ratio and Left Ventricular Ejection Fraction in Congestive Heart Failure
Philbin, E. F. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.5.501 · Cited by 53
Assessment of a low-intensity cardiac rehabilitation programme using the six-minute walk test
Wright, D. J., Khan, K. M., Gossage, E. M., & Saltissi, S. (2001) · Clinical Rehabilitation · doi:10.1191/026921501671364449 · Cited by 53
Nitrates in the treatment of congestive heart failure
Elkayam, U. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00188-9 · Cited by 53
Review of randomized trials of digoxin therapy in patients with chronic heart failure
Gheorghiade, M., & Zarowitz, B. J. M. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91254-2 · Cited by 53
Baseline Demographics of the Valsartan Heart Failure Trial
Cohn, J. N., Tognoni, G., Glazer, R. D., Spormann, D., & Val-HeFT Investigators (2000) · European Journal of Heart Failure · doi:10.1016/s1388-9842(00)00130-6 · Cited by 55
Self-citation
BiDil for Heart Failure in Black Patients: Implications of the U.S. Food and Drug Administration Approval
Bibbins-Domingo, K. B., & Fernández, A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-1-200701020-00009 · Cited by 54
Recognition and treatment
Jevon, P. (2010) · Cited by 52
Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial
Lewis, E. F., Claggett, B. L., Shah, A. M., Liu, J., Shah, S. J., Anand, I. S., O’Meara, E., Sweitzer, N. K., Rouleau, J. L., Fang, J. C.-T., et al. (2018) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.004457 · Cited by 52
Nitric Oxide Donors: Biochemical Pharmacology and Therapeutics
Bauer, J. A., Booth, B. P., & Fung, H. (1995) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61098-4 · Cited by 52
Brief review: Angiotensin converting enzyme inhibitors and angioedema: anesthetic implications
Sarkar, P., Nicholson, G., & Hall, G. (2006) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03022528 · Cited by 52
Modifiable Risk Factors for Incident Heart Failure in the Coronary Artery Surgery Study
Hoffman, R. M. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420040081012 · Cited by 54
Pharmacological Modulation of Cardiovascular Remodeling: A Guide to Heart Failure Therapy
Remme, W. J. (2003) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1027351808326 · Cited by 52
Effect of Metoprolol CR/XL on Exercise Tolerance in Chronic Heart Failure — a Substudy to the MERIT-HF Trial
Gullestad, L. L., Cord, M., Torbjørn, A., Skåardal, R., Hans, F., Wikstrand, J., & Kjekshus, J. (2001) · European Journal of Heart Failure · doi:10.1016/s1388-9842(01)00146-5 · Cited by 52
PROGNOSIS IN CONGESTIVE HEART FAILURE
Rector, T. S., & Cohn, J. N. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.341 · Cited by 52
Self-citation
Relation of pathophysiologic mechanisms to outcome in heart failure
Poole-Wilson, P. A. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90458-d · Cited by 52
Monitoring of pulmonary arterial diastolic pressure through a right ventricular pressure transducer
Ohlsson, Å., Bennett, T., Nordlander, R., Rydén, J., Åström, H., & Rydén, L. (1995) · Journal of Cardiac Failure · doi:10.1016/1071-9164(95)90018-7 · Cited by 52
Has the survival of the heart failure population changed? lessons from trials
Cleland, J. G. F., & Clark, A. L. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)01011-x · Cited by 52
Increased intra-QRS fragmentation in magnetocardiography as a predictor of arrhythmic events and mortality in patients with cardiac dysfunction after myocardial infarction
KORHONEN, P., HUSA, T., TIERALA, I., VÄÄNÄNEN, H., MÄKIJÄRVI, M., KATILA, T., & TOIVONEN, L. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2005.00332.x · Cited by 51
Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure
Packer, M., & McMurray, J. J. V. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30969-2 · Cited by 51
Continuous-Flow Production of Isosorbide from Aqueous-Cellulosic Derivable Feed over Sustainable Heterogeneous Catalysts
Brandi, F., Khalil, I., Antonietti, M., & Al‐Naji, M. (2020) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.0c08167 · Cited by 52
Evaluation of the management of heart failure in primary care
Calvert, M., Shankar, A., McManus, R. J., Ryan, R. P., & Freemantle, N. (2009) · Family Practice · doi:10.1093/fampra/cmn105 · Cited by 51
Echocardiography Should Be Performed in All Elderly Patients with Congestive Heart Failure*
Aronow, W. S. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb06516.x · Cited by 51
A Decade of Clinical Trial Developments in Postmyocardial Infarction, Congestive Heart Failure, and Sustained Ventricular Tachyarrhythmia Patients: From CAST to AVID and Beyond
NACCARELLLI, G. V., Wolbrette, D. L., Dell’Orfano, J. T., Patel, H. M., & Luck, J. C. (1998) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1998.tb00127.x · Cited by 51
Women and mexican Americans receive fewer cardiovascular drugs following myocardial infarction than men and non-hispanic whites: The Corpus Christi Heart Project, 1988–1990
Herholz, H., Goff, D. C., Ramsey, D. J., Chan, F. A., Ortiz, C., Labarthe, D. R., & Nichaman, M. Z. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00572-2 · Cited by 51
Exhaled nitric oxide as a marker for organic nitrate tolerance.
Husain, M., Adrie, C., Ichinose, F., Kavosi, M., & Zapol, W. M. (1994) · Circulation · doi:10.1161/01.cir.89.6.2498 · Cited by 51
Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy
Fujimura, M., Yasumura, Y., Ishida, Y., Nakatani, S., Komamura, K., Yamagishi, M., & Miyatake, K. (2000) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(00)80004-4 · Cited by 51
Comparison of the epidemiology and co-morbidities of heart failure in the pediatric and adult populations: a retrospective, cross-sectional study
Webster, G., Zhang, J., & Rosenthal, D. N. (2006) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-6-23 · Cited by 50
Ten renin‐angiotensin system‐related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure
Zakrzewski‐Jakubiak, M., de Denus, S., Dubé, M., Bélanger, F., White, M., & Turgeon, J. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03091.x · Cited by 50
Narrative Review: Pharmacotherapy for Chronic Heart Failure: Evidence from Recent Clinical Trials
Yan, A. T.-K., Yan, R. T., & Liu, P. P. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-2-200501180-00013 · Cited by 50
Comparison of single-dose nifedipine and captopril for chronic severe aortic regurgitation
Röthlisberger, C., Sareli, P., & Wisenbaugh, T. W. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)91065-p · Cited by 50
Mechanisms of Arrhythmias in Heart Failure
VERMEULEN, J. T. (1998) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1998.tb00902.x · Cited by 50
Neuroendocrine changes in heart failure and their clinical relevance
Parmley, W. W. (1995) · Clinical Cardiology · doi:10.1002/clc.4960180804 · Cited by 50
Quality of care for patients hospitalized with heart failure at academic medical centers
Nohria, A., Chen, Y.-T., Morton, D. J., Walsh, R., Vlasses, P. H., & Krumholz, H. M. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70358-3 · Cited by 50
Association is not causation: treatment effects cannot be estimated from observational data in heart failure
Rush, C. J., Campbell, R. T., Jhund, P. S., Petrie, M. C., & McMurray, J. J. V. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy407 · Cited by 52
The role of extracellular matrix in age-related conduction disorders: a forgotten player?
Spadaccio, C., Rainer, A., Mozetic, P., Trombetta, M., Dion, R. A., Barbato, R., Nappi, F., & Chello, M. (2015) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2015.01.009 · Cited by 52
Prevention, Diagnosis, and Treatment of Hypertensive Heart Disease
Georgiopoulou, V. V., Kalogeropoulos, A. P., Raggi, P., & Butler, J. (2010) · Cardiology Clinics · doi:10.1016/j.ccl.2010.07.005 · Cited by 50
Leveraging Signaling Pathways to Treat Heart Failure With Reduced Ejection Fraction
Pinilla-Vera, M., Hahn, V. S., & Kass, D. A. (2019) · Circulation Research · doi:10.1161/circresaha.119.313682 · Cited by 52
Guía de práctica clínica de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica (2008)
(2008), G. D. T. D. L. E. P. E. D. Y. T. D. L. I. C. A. Y. C., & Desarrollada en colaboración con la Heart Failure Association (HFA) de la ESC y aprobada por la European Society of Intensive Care Medicine (ESICM) (2008) · Revista Española de Cardiología · doi:10.1016/s0300-8932(08)75740-3 · Cited by 50
Pathophysiology of heart failure and the renin-angiotensin-system
Holtz, J. (1993) · Steinkopff eBooks · doi:10.1007/978-3-642-72497-8_13 · Cited by 49
Peripartum cardiomyopathy
Baughman, K. L. (2001) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-001-0021-x · Cited by 49
Enalapril Reduces QTc Dispersion in Mild Congestive Heart Failure Secondary to Coronary Artery Disease
Barr, C. S., Naas, A. A., Fenwick, M., & Struthers, A. D. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00756-4 · Cited by 49
Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure
Carson, P. E. (2000) · American Heart Journal · doi:10.1067/mhj.2000.109215 · Cited by 49
Self-citation
Are there age and sex differences in the investigation and treatment of heart failure? A population-based study.
Hood, S. G., Taylor, S. J., Roeves, A., Crook, A. M., Tlusty, P., Cohen, J., Kaddoura, S., & Hemingway, H. (2000) · Europe PMC (PubMed Central) · Cited by 49
Heart Failure in Non-Caucasians, Women, and Older Adults: A White Paper on Special Populations From the Heart Failure Society of America Guideline Committee
Colvin, M. M., Sweitzer, N. K., Albert, N. M., Krishnamani, R., Rich, M. W., Stough, W. G., Walsh, M. N., Canary, C. A. W., Allen, L. A., Bonnell, M. R., et al. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.05.013 · Cited by 50
Self-citation
Pregnancy and peripartum cardiomyopathy: a comparative and prospective study
Ávila, W. S., de Carvalho, M. E. C., Tschaen, C. K., Rossi, E. G., Grinberg, M., Mady, C., & Ramires, J. A. F. (2002) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2002001400006 · Cited by 48
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure
Aimo, A., Vergaro, G., Castiglione, V., Barison, A., Pasanisi, E., Petersen, C., Chubuchny, V., Giannoni, A., Poletti, R., Maffei, S., et al. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2017.07.011 · Cited by 48
Reliability of Ventricular Remodeling as a Surrogate for Use in Conjunction With Clinical Outcomes in Heart Failure
Konstam, M. A. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.05.037 · Cited by 48
The ESPRIM trial: short-term treatment of acute myocardial infarction with molsidomine*1
EUROPEANSTUDYOFPREVENTIONOFIN (1994) · The Lancet · doi:10.1016/s0140-6736(94)91282-3 · Cited by 48
Effects of sustained β-adrenergic stimulation on ionic currents of cultured adult guinea pig cardiomyocytes
Zhang, L., Wang, Z., & Nattel, S. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01138.2000 · Cited by 48
Value of Digoxin in Heart Failure and Sinus Rhythm: New Features of an Old Drug?
van Veldhuisen, D. J., de Graeff, P. A., Remme, W. J., & Lie, K. I. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00247-1 · Cited by 48
Observation Unit Management of Heart Failure
Peacock, W. F., & Albert, N. M. (2001) · Emergency Medicine Clinics of North America · doi:10.1016/s0733-8627(05)70176-0 · Cited by 48
Effects of imidapril on NOS expression and myocardial remodelling in failing heart of Dahl salt-sensitive hypertensive rats
Kobayashi, N. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00237-0 · Cited by 48
Sacubitril/Valsartan (LCZ696) in Heart Failure
Khder, Y., Shi, V. C., McMurray, J. J. V., & Lefkowitz, M. P. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_77 · Cited by 47
CaMKII and PKA-dependent phosphorylation co-regulate nuclear localization of HDAC4 in adult cardiomyocytes
Helmstadter, K. G., Ljubojević-Holzer, S., Wood, B. M., Taheri, K. D., Sedej, S., Erickson, J. R., Bossuyt, J., & Bers, D. M. (2021) · Basic Research in Cardiology · doi:10.1007/s00395-021-00850-2 · Cited by 47
Reporting Risks and Benefits of Therapy by Use of the Concepts of Unqualified Success and Unmitigated Failure
Mancini, G. B. J., & Schulzer, M. (1999) · Circulation · doi:10.1161/01.cir.99.3.377 · Cited by 47
Memory function in patients with stable, moderate to severe cardiac failure
Grubb, N. R., Simpson, C., & Fox, K. A. A. (2000) · American Heart Journal · doi:10.1067/mhj.2000.106647 · Cited by 47
Guías de actuación clínica de la Sociedad Española de Cardiología. Recomendaciones para el uso del tratamiento antitrombótico en cardiología
Heras, M., Fernández‐Ortíz, A., Guindal, J. A. G., Iriarte, J. A., Lidón, R. M., Gómez, F. J. B., & Roldán, I. (1999) · Revista Española de Cardiología · doi:10.1016/s0300-8932(99)75009-8 · Cited by 47
Cellular and molecular aspects of myocardial dysfunction
Schwartz, S. M., Duffy, J. Y., Pearl, J. M., & Nelson, D. P. (2001) · Critical Care Medicine · doi:10.1097/00003246-200110001-00003 · Cited by 47
Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failure.
Davidson, N. C., Coutie, W. J., Webb, D. J., & Struthers, A. D. (1996) · Heart · doi:10.1136/hrt.75.6.576 · Cited by 47
The design of the mortality assessment in congestive heart failure trial (MACH‐1, Mibefradil)
Levine, T. B. (1997) · Clinical Cardiology · doi:10.1002/clc.4960200404 · Cited by 47
Improvements in clinical outcomes with the use of angiotensin-converting enzyme inhibitors: cross-fertilization between clinical and basic investigation
Pfeffer, M. A., & Frohlich, E. D. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00647.2006 · Cited by 47
Sustainable Sorbitol Dehydration to Isosorbide using Solid Acid Catalysts: Transition from Batch Reactor to Continuous‐Flow System
Brandi, F., & Al‐Naji, M. (2021) · ChemSusChem · doi:10.1002/cssc.202102525 · Cited by 47
Renin-Angiotensin-Aldosterone Blockade for Cardiovascular Disease Prevention
Vijayaraghavan, K., & DEEDWANIA, P. C. (2011) · Cardiology Clinics · doi:10.1016/j.ccl.2010.11.003 · Cited by 46
The diagnosis and management of chronic heart failure: review following the publication of the NICE guidelines
Al‐Mohammad, A., & Mant, J. (2011) · Heart · doi:10.1136/hrt.2010.214999 · Cited by 46
Clinical Profile and Management of Heart Failure: Rural Community Hospital vs. Metropolitan Heart Center
TAUBERT, G., Bergmeier, C., Andresen, H., Senges, J., & Potratz, J. (2001) · European Journal of Heart Failure · doi:10.1016/s1388-9842(01)00142-8 · Cited by 47
Natural history of incidentally discovered, asymptomatic idiopathic dilated cardiomyopathy
Redfield, M. M., Gersh, B. J., Bailey, K. R., & Rodeheffer, R. J. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90323-9 · Cited by 46
Effects of long-term administration of enalapril on clinical indicators of renal function in dogs with compensated mitral regurgitation
Atkins, C. E., Brown, W. A., Coats, J. R., Crawford, M. A., DeFrancesco, T. C., Edwards, J., Fox, P. R., Keene, B. W., Lehmkuhl, L. B., Luethy, M. W., et al. (2002) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.2002.221.654 · Cited by 46
Interobserver discordance in the classification of mechanisms of death in studies of heart failure
Ziesche, S., Rector, T. S., & Cohn, J. N. (1995) · Journal of Cardiac Failure · doi:10.1016/1071-9164(95)90014-4 · Cited by 46
Self-citation
Nonexcitatory electrical signals for enhancing ventricular contractility: rationale and initial investigations of an experimental treatment for heart failure
Burkhoff, D., & Ben‐Haim, S. A. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01311.2004 · Cited by 46
Inotropic Therapy for Heart Failure — An Unfulfilled Promise
Curfman, G. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252111 · Cited by 46
Targeting the autonomic nervous system: Measuring autonomic function and novel devices for heart failure management
Patel, H. C., Rosen, S. D., Lindsay, A. C., Hayward, C., Lyon, A. R., & Mario, C. D. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.10.058 · Cited by 45
The ESCAPE Investigators and ESCAPE Study Coordinators* ESCAPE Trial Pulmonary Artery Catheterization Effectiveness: The Evaluation Study of Congestive Heart Failure and
Hall, J. B. (2009) · Cited by 45
Left ventricular hypertrophy: An initial response to myocardial injury
Francis, G. S., & McDonald, K. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91249-4 · Cited by 45
Self-citation
ACE inhibitors for heart failure: a question of dose
Cleland, J. G. F., & Poole-Wilson, P. A. (1994) · Heart · doi:10.1136/hrt.72.3_suppl.s106 · Cited by 45
Angiotensin-converting-enzyme inhibitors in the management of cardiac failure: are we ignoring the evidence?
Hillis, G. S., Trent, R. J., Winton, P., MacLeod, A., & Jennings, K. (1996) · QJM · doi:10.1093/qjmed/89.2.145 · Cited by 45
Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes
Albaghdadi, M. S., Gheorghiade, M., & Pitt, B. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr170 · Cited by 44
Long-Term Effects of Flosequinan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure
Packer, M., Pitt, B., Rouleau, J. L., Swedberg, K. B., DeMets, D. L., & Fisher, L. D. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2017.03.003 · Cited by 45
Peripartum cardiomyopathy
Moioli, M., Menada, M. V., Bentivoglio, G., & Ferrero, S. (2009) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-1170-5 · Cited by 44
Heart Failure in Older Adults
Rich, M. W. (2006) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.05.012 · Cited by 44
Time trends in the use of β-blockers and other pharmacotherapies in older adults with congestive heart failure
Smith, N. L., Chan, J. D., Rea, T. D., Wiggins, K. L., Gottdiener, J. S., Lumley, T., & Psaty, B. M. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.04.002 · Cited by 44
G-Protein Beta-3 Subunit Genotype Predicts Enhanced Benefit of Fixed-Dose Isosorbide Dinitrate and Hydralazine
McNamara, D. M., Taylor, A. L., Tam, S. W., Worcel, M., Yancy, C. W., Hanley‐Yanez, K., Cohn, J. N., & Feldman, A. M. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.04.016 · Cited by 43
Self-citation
A pathway and network review on beta-adrenoceptor signaling and beta blockers in cardiac remodeling
Yang, J., Liu, Y., Fan, X., Li, Z., & Cheng, Y. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9417-4 · Cited by 43
A review of heart failure treatment.
Guyatt, G. H., & Devereaux, P. J. (2004) · PubMed · Cited by 43
Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril
Kasama, S., Toyama, T., Kumakura, H., Takayama, Y., Ichikawa, S., Suzuki, T., & Kurabayashi, M. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1786-z · Cited by 43
Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure.
Schwarz, M., Katz, S. D., Demopoulos, L. A., Hirsch, H., Yuen, J., Jondeau, G., & LeJemtel, T. H. (1994) · Circulation · doi:10.1161/01.cir.89.4.1609 · Cited by 43
Ten year survival after heart transplantation: palliative procedure or successful long term treatment?
Fraund, S., Pethig, K., Franke, U. F. W., Wahlers, T., Harringer, W., Cremer, J., Fieguth, H.-G., Oppelt, P., & Haverich, A. (1999) · Heart · doi:10.1136/hrt.82.1.47 · Cited by 43
Losartan
Simpson, K. L., & McClellan, K. J. (2000) · Drugs & Aging · doi:10.2165/00002512-200016030-00006 · Cited by 43

Authors: Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., Bhat, G., Goldman, S., Fletcher, R. D., Doherty, J., Hughes, C. V., Carson, P., Cintron, G., Shabetai, R., & Haakenson, C.
Affiliations: University of Minnesota (US)
ORCID: Cohn, Jay N.
Johnson, Gary
Bhat, Geetha
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08
Volume: 325
Issue: 5
Pages: 303-310
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108013250502
OpenAlex: W2046383587
Cited by: 2,833
References: 19
Citations by year: 2026: 14 · 2025: 15 · 2024: 26 · 2023: 21 · 2022: 31 · 2021: 27 · 2020: 46 · 2019: 39 · 2018: 51 · 2017: 56 · 2016: 69 · 2015: 59 · 2014: 54 · 2013: 61 · 2012: 56
FWCI: 124.25
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: enalapril, hydralazine, isosorbide dinitrate, chronic congestive heart failure, vasodilator therapy, mortality, sudden death, exercise oxygen consumption, left ventricular ejection fraction, ACE inhibitors, combination therapy, digoxin, diuretics, NYHA functional class
MeSH terms: Adolescent, Adult, Aged, Chronic Disease, Death, Sudden, Double-Blind Method, Drug Administration Schedule, Drug Therapy, Combination, Enalapril, Physical Exertion, Heart Failure, Hospitalization, Humans, Hydralazine, Isosorbide Dinitrate, Male, Middle Aged, Norepinephrine, Oxygen Consumption, Patient Compliance, Stroke Volume, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks